After hundreds of audits, and after preparing medical device companies for FDA inspections and notified body assessments, our team at MB&A has watched the same pattern repeat across company sizes, quality maturity levels, and product categories.
The company has good documentation. The team is well prepared. The records are organized. And the auditor still issues findings.
Not because of a paperwork problem. Because of a quality intelligence problem.
A recent Quality Digest analysis captures the first half of this picture well: audits fail not because documentation is missing, but because information can't be found, verified, or acted on consistently when it matters. The connected worker platforms and AI-assisted documentation tools it describes solve real problems. When Blue Buffalo improved audit scores by 75 percent and General Mills cut training time by more than 60 percent through digital work instructions and embedded training, those results reflect real operational improvement.
But in our experience running audits and preparing clients for them, access to documentation is the floor, not the ceiling.
What we see in the field
When MB&A runs a gap assessment or prepares a client for an inspection, we spend a lot of our time on something most quality teams don't think to show us: the space between systems.
Your QMS has data. Your complaint system has data. Your supplier quality records have data. Your CAPA logs have data. In almost every engagement, those systems run in silos, each reporting its own metrics, none of them talking to the others in a way that brings cross-system risk to the surface.
That's where findings live before they're findings.
A CAPA that's technically closed, but with a corrective action that hasn't been checked for effectiveness. Complaint volume trending upward in one device family that no single report catches, because no individual complaint type crosses its threshold. A design control gap from a previous audit cycle that connects to a current supplier deviation. That connection is real and meaningful, and completely invisible if you aren't looking across systems at the same time.
We've seen companies walk into FDA inspections with pristine documentation and leave with multiple 483 observations, all traceable to process drift that was there months before the inspection, visible in the data, and missed because no one was watching the right signals.
The distinction that matters
In our practice, we've started drawing a clear line for clients between two states:
Audit-ready means you can demonstrate compliance when required. Your records are accessible, your staff is prepared, your procedures are current. This is necessary. It isn't sufficient.
Audit-intelligent means your quality system is continuously watching its own performance, catching drift before it becomes a deviation, before a deviation becomes a finding, before a finding becomes a consent decree. You aren't waiting for an auditor to tell you something is wrong. You know first.
Getting from audit-ready to audit-intelligent takes two things: an honest assessment of where your quality signals actually live and what they're telling you, and a way to watch those signals continuously.
Most of our clients already meet the first condition. Their data exists. The gap is continuous monitoring and seeing across systems.
What audit-intelligent quality systems look like in practice
The quality leaders whose companies do best in inspections have one thing in common. They can tell an auditor a coherent story about how their quality system performs over time. Not just “here are our records,” but “here's our CAPA effectiveness trend, here's how our complaint velocity maps to our risk management reviews, here's how we found and fixed this process deviation six weeks before you arrived.”
That story is built from continuous monitoring, not from pre-inspection preparation.
Building that capability starts with three honest questions:
- Do you know where your quality signals live? Not just in your QMS, but across your complaint system, supplier portal, design controls, and post-market surveillance data?
- Do you have thresholds for drift, not just for compliance? The difference between a leading indicator (CAPA effectiveness rate trending down) and a lagging one (CAPA count at quarter end) is everything.
- Can you connect signals across systems? Or does each system report on its own, leaving the connections for an auditor to make?
MB&A's approach: audit intelligence as a practice
Our audit intelligence work goes beyond mock audits and procedure reviews. We run structured quality signal assessments: mapping where data lives, finding the connections across systems, and building the governance for continuous monitoring.
On the audits where it fits, we use Qualera, the audit intelligence platform Monica Burt founded in 2025. It gives the auditor a first read of a company's documents and records before the work starts, and an MB&A lead auditor reviews and decides every finding.
The result for quality leaders is a different kind of audit readiness: not a sprint before the inspection, but a steady state of quality intelligence that makes the inspection a formality rather than a test.
What quality leaders should assess today
- Map your signal landscape. List your quality data sources (QMS, CAPA, complaints, supplier quality, post-market surveillance) and find where they don't connect. That's your risk map.
- Review your leading indicators. Are you tracking CAPA effectiveness, not just CAPA count? Complaint velocity by product family, not just total volume? Supplier deviation trends, not just pass/fail rates?
- Test your audit story. Could your quality team tell an auditor a coherent story about quality system performance over the last 12 months, not just confirm that records exist?
- Look honestly at your inspection history. If you've received 483 observations or major findings in recent cycles, trace them backward. Were the signals there before the inspection? Almost always, they were.
- Separate documentation from intelligence. Digitizing SOPs and embedding training is valuable. Knowing whether those processes are actually performing as designed is a different, additional capability.
The audit-intelligent future is already here
The Quality Management System Regulation (QMSR), EU MDR requirements, and FDA's increasingly data-driven inspections all point to the same expectation: quality systems that show continuous performance, not just periodic compliance paperwork.
The companies building audit-intelligent quality systems today aren't preparing for the future. They're meeting the current standard, and putting themselves in a position to lead their regulatory relationships rather than just survive them.
MB&A helps medical device companies build audit-intelligent quality systems. Talk with us about your audit readiness.
Source: Scott Ginsberg, “The Audit-Ready Factory,” Quality Digest, March 25, 2026.